CoChat

The HMGA2-IMP2 Pathway Promotes Granulosa Cell Proliferation in Polycystic Ovary Syndrome

Open access
Li, Miao, Zhao, Han, Zhao, Shi-Gang, Wei, Dai-Min, Zhao, Yue-Ran, Huang, Tao, Muhammad, Tahir, Yan, Lei, Gao, Fei, Li, Lei, Lu, Gang, Chan, Wai-Yee, Leung, Peter C K, Dunaif, Andrea, Liu, Hong-Bin, Chen, Zi-Jiang · 2019 · The Journal of Clinical Endocrinology & Metabolism
Cited by 64

The DOI matches its Crossref record; 11 of the 11 references it cites were found in a registry or an index.

Abstract

Context: The high mobility group AT hook 2 (HMGA2) gene was previously identified in a genome-wide association study as a candidate risk gene that might be related to polycystic ovary syndrome (PCOS). Whether HMGA2 contributes to promoting granulosa cell (GC) proliferation in PCOS remains unknown. Objective: We sought to determine whether HMGA2 is involved in the ovarian dysfunction of PCOS and in the mechanism of increased GC proliferation. Patients and Cells: mRNA expression was analyzed in ovarian GCs from 96 women with PCOS and 58 healthy controls. Immortalized human GCs (KGN and SVOG cells) were used for the mechanism study. Main Outcome Measures: mRNA expression in ovarian GCs was measured using quantitative RT-PCR, and KGN cells were cultured for proliferation assays after overexpression or knockdown of target genes. Protein expression analysis, luciferase assays, and RNA binding protein immunoprecipitation assays were used to confirm the mechanism study. Results: HMGA2 and IGF2 mRNA binding protein 2 (IMP2) were highly expressed in the GCs of women with PCOS, and the HMGA2/IMP2 pathway promoted GC proliferation. Cyclin D2 and SERPINE1 mRNA binding protein 1 were regulated by IMP2 and were highly expressed in women with PCOS. Conclusions: The HMGA2/IMP2 pathway was activated in women with PCOS and promoted the proliferation of GCs. This might provide new insights into the dysfunction of GCs in PCOS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2018-00544

Cites

11 of 11 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 11 references

Research works printed but not linked: 38

  1. Reeves, 1990, The A.T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: a novel peptide motif for recognizing DNA structure, J Biol Chem, 265, 8573, 10.1016/S0021-9258(19)38926-4 · DOI · Paper page
  2. Weedon, 2007, A common variant of HMGA2 is associated with adult and childhood height in the general population, Nat Genet, 39, 1245, 10.1038/ng2121 · DOI · Paper page
  3. Voight, 2010, Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis, Nat Genet, 42, 579, 10.1038/ng.609 · DOI · Paper page
  4. Zhou, 1998, HMGI family proteins: architectural transcription factors in mammalian development and cancer, Keio J Med, 47, 73, 10.2302/kjm.47.73 · DOI
  5. Fedele, 2006, HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity, Cancer Cell, 9, 459, 10.1016/j.ccr.2006.04.024 · DOI · Paper page
  6. Asher, 1995, Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains, Cell, 82, 57, 10.1016/0092-8674(95)90052-7 · DOI · Paper page
  7. Anand, 2000, In vivo modulation of Hmgic reduces obesity, Nat Genet, 24, 377, 10.1038/74207 · DOI · Paper page
  8. Brants, 2004, Differential regulation of the insulin-like growth factor II mRNA-binding protein genes by architectural transcription factor HMGA2, FEBS Lett, 569, 277, 10.1016/j.febslet.2004.05.075 · DOI · Paper page
  9. Christiansen, 2009, IGF2 mRNA-binding protein 2: biological function and putative role in type 2 diabetes, J Mol Endocrinol, 43, 187, 10.1677/JME-09-0016 · DOI · Paper page
  10. Erickson, 1992, Granulosa cells of polycystic ovaries: are they normal or abnormal, Hum Reprod, 7, 293, 10.1093/oxfordjournals.humrep.a137638 · DOI · Paper page
  11. Hughesdon, 1982, Morphology and morphogenesis of the Stein-Leventhal ovary and of so-called “hyperthecosis, Obstet Gynecol Surv, 37, 59, 10.1097/00006254-198202000-00001 · DOI · Paper page
  12. Stubbs, 2007, Abnormal preantral folliculogenesis in polycystic ovaries is associated with increased granulosa cell division, J Clin Endocrinol Metab, 92, 4418, 10.1210/jc.2007-0729 · DOI · Paper page
  13. Das, 2008, Granulosa cell survival and proliferation are altered in polycystic ovary syndrome, J Clin Endocrinol Metab, 93, 881, 10.1210/jc.2007-1650 · DOI · Paper page
  14. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group, 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril, 81, 19, 10.1016/j.fertnstert.2003.10.004 · DOI · Paper page
  15. Iwase, 2009, Insulin attenuates the insulin-like growth factor-I (IGF-I)-Akt pathway, not IGF-I-extracellularly regulated kinase pathway, in luteinized granulosa cells with an increase in PTEN, J Clin Endocrinol Metab, 94, 2184, 10.1210/jc.2008-1948 · DOI
  16. Schmittgen, 2008, Analyzing real-time PCR data by the comparative C(T) method, Nat Protoc, 3, 1101, 10.1038/nprot.2008.73 · DOI · Paper page
  17. Gallardo, 2007, Genomewide discovery and classification of candidate ovarian fertility genes in the mouse, Genetics, 177, 179, 10.1534/genetics.107.074823 · DOI
  18. Mahajan, 2010, HMGA2: a biomarker significantly overexpressed in high-grade ovarian serous carcinoma, Mod Pathol, 23, 673, 10.1038/modpathol.2010.49 · DOI
  19. Pfannkuche, 2009, The high mobility group protein HMGA2: a co-regulator of chromatin structure and pluripotency in stem cells, Stem Cell Rev, 5, 224, 10.1007/s12015-009-9078-9 · DOI
  20. Li, 2013, Oncogenic NRAS, required for pathogenesis of embryonic rhabdomyosarcoma, relies upon the HMGA2-IGF2BP2 pathway, Cancer Res, 73, 3041, 10.1158/0008-5472.CAN-12-3947 · DOI · Paper page
  21. Li, 2012, An HMGA2-IGF2BP2 axis regulates myoblast proliferation and myogenesis, Dev Cell, 23, 1176, 10.1016/j.devcel.2012.10.019 · DOI · Paper page
  22. Sicinski, 1996, Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis, Nature, 384, 470, 10.1038/384470a0 · DOI · Paper page
  23. Peluso, 2013, Plasminogen activator inhibitor 1 RNA-binding protein interacts with progesterone receptor membrane component 1 to regulate progesterone’s ability to maintain the viability of spontaneously immortalized granulosa cells and rat granulosa cells, Biol Reprod, 88, 20, 10.1095/biolreprod.112.103036 · DOI · Paper page
  24. Cui, 2012, Genotype-phenotype correlations of PCOS susceptibility SNPs identified by GWAS in a large cohort of Han Chinese women, Hum Reprod, 28, 538, 10.1093/humrep/des424 · DOI · Paper page
  25. McAllister, 2015, Functional genomics of PCOS: from GWAS to molecular mechanisms, Trends Endocrinol Metab, 26, 118, 10.1016/j.tem.2014.12.004 · DOI · Paper page
  26. Ben-Haim, 2014, FTO: linking m6A demethylation to adipogenesis, Cell Res, 25, 3, 10.1038/cr.2014.162 · DOI
  27. Frayling, 2007, A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity, Science, 316, 889, 10.1126/science.1141634 · DOI · Paper page
  28. Cleynen, 2007, HMGA2 regulates transcription of the Imp2 gene via an intronic regulatory element in cooperation with nuclear factor–kappaB, Mol Cancer Res, 5, 363, 10.1158/1541-7786.MCR-06-0331 · DOI · Paper page
  29. Franks, 2000, Follicular dynamics in the polycystic ovary syndrome, Mol Cell Endocrinol, 163, 49, 10.1016/S0303-7207(99)00239-7 · DOI · Paper page
  30. Hillier, 1994, Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis, Hum Reprod, 9, 188, 10.1093/oxfordjournals.humrep.a138480 · DOI · Paper page
  31. Jiang, 2015, MicroRNA-93 promotes ovarian granulosa cells proliferation through targeting CDKN1A in polycystic ovarian syndrome, J Clin Endocrinol Metab, 100, E729, 10.1210/jc.2014-3827 · DOI
  32. Cai, 2016, MicroRNA-145 negatively regulates cell proliferation through targeting IRS1 in isolated ovarian granulosa cells from patients with polycystic ovary syndrome, Reprod Sci, 24, 902, 10.1177/1933719116673197 · DOI
  33. Wang, 2017, Functional characterization of microRNA-27a-3p expression in human polycystic ovary syndrome, Endocrinology, 159, 297, 10.1210/en.2017-00219 · doi:10.1210/en.2017-00219
  34. Zhao, 2015, Up-regulated expression of WNT5a increases inflammation and oxidative stress via PI3K/AKT/NF-κB signaling in the granulosa cells of PCOS patients, J Clin Endocrinol Metab, 100, 201, 10.1210/jc.2014-2419 · DOI · Paper page
  35. Nishi, 2001, Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor, Endocrinology, 142, 437, 10.1210/endo.142.1.7862 · doi:10.1210/endo.142.1.7862 · Paper page
  36. Lie, 1996, Long-term growth and steroidogenic potential of human granulosa-lutein cells immortalized with SV40 large T antigen, Mol Cell Endocrinol, 120, 169, 10.1016/0303-7207(96)03835-X · doi:10.1016/0303-7207(96)03835-x
  37. Ayoubi, 1999, Regulation of HMGIC expression: an architectural transcription factor involved in growth control and development, Oncogene, 18, 5076, 10.1038/sj.onc.1202881 · DOI
  38. Markowski, 2013, HMGA2 expression in white adipose tissue linking cellular senescence with diabetes, Genes Nutr, 8, 449, 10.1007/s12263-013-0354-6 · DOI

Cited by

Metadata

Authors
Li, M., Zhao, H., Zhao, S.-G., Wei, D.-M., Zhao, Y.-R., Huang, T., Muhammad, T., Yan, L., Gao, F., Li, L., Lu, G., Chan, W.-Y., Leung, P. C. K., Dunaif, A., Liu, H.-B., & Chen, Z.-J.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2018-09-21
Volume
104
Issue
4
Pages
1049-1059
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2890422552
Cited by
64
References
11
FWCI
3.37
Type
journal article
Language
en
Open access
bronze
Funders
  • National Natural Science Foundation of China (81771538, 31601199, 81200423)
  • Young Scholars Program of Shandong University (2016WLJH50)
  • Natural Science Foundation of Shandong Province (ZR2017MH049, ZR2016HQ38)
  • National Institutes of Health (1R01HD085527)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.